STOCK TITAN

[Form 4] ORACLE CORP Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4

Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.

Oracle (ORCL) ha riportato una transazione interna su un modulo Form 4. Il 10/10/2025, un dirigente (EVP, Chief Legal Officer) ha venduto 19.758 azioni ordinarie al prezzo di $300 per azione, codificata come “S.” A seguito della vendita, l’ufficiale deteneva direttamente 18.429 azioni. Il deposito indica che la vendita è stata effettuata nell’ambito di un piano di negoziazione Rule 10b5-1 adottato il 10 luglio 2025.

Oracle (ORCL) informó una operación de insider en un Formulario 4. El 10/10/2025, un ejecutivo (EVP, Chief Legal Officer) vendió 19,758 acciones comunes a $300 por acción, codificado como “S.” Tras la venta, el ejecutivo poseía beneficiosamente 18,429 acciones, en forma directa. El registro señala que la venta se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 10 de julio de 2025.

Oracle (ORCL)은 Form 4에 내부자 거래를 보고했습니다. 2025년 10월 10일, 한 임원(EVP, 법무 최고책임자)이 일반주식 19,758주를 주당 $300에 매도했으며, 거래 유형은 “S.”로 표기됩니다. 매도 후 임원은 직접적으로 18,429주를 보유하고 있었습니다. 제출 문서는 매도가 2025년 7월 10일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 기록합니다.

Oracle (ORCL) a rapporté une transaction d’initié sur un formulaire Form 4. Le 10/10/2025, un dirigeant (EVP, Directeur juridique) a vendu 19 758 actions ordinaires à $300 par action, codé « S ». Suite à la vente, l’officier était bénéficiairement propriétaire de 18 429 actions, détenues directement. Le dossier précise que la vente a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 10 juillet 2025.

Oracle (ORCL) meldete eine Insider-Transaktion auf Formular 4. Am 10.10.2025 verkaufte ein Beauftragter (EVP, Chief Legal Officer) 19.758 Stammaktien zu $300 pro Aktie, codiert „S“. Nach dem Verkauf hielt der Beauftragte direkt 18.429 Aktien im Eigentum. Die Einreichung vermerkt, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelplans adoptiert am 10. Juli 2025 stattfand.

Oracle (ORCL) أبلغت عن صفقة داخلية في نموذج 4 Form. في 10/10/2025، باحث (EVP، رئيس الشؤون القانونية) باع 19,758 سهماً من الأسهم العادية بسعر $300 للسهم، مُرمَّز بـ"S". بعد البيع، امتلك الضابط 18,429 سهماً بشكل فعلي، مملوكة مباشرة. تشير الوثيقة إلى أن البيع تمت بموجب خطة تداول Rule 10b5-1 اعتمدت في 10 يوليو 2025.

Oracle (ORCL) 报告了在 Form 4 上的内幕交易。2025年10月10日,一位高管(EVP,首席法务官)以每股 $300 的价格出售了 19,758 股普通股,代码为“S”。交易后,该高管直接持有 18,429 股普通股。备案显示,该交易是基于于 2025年7月10日通过的 Rule 10b5-1 交易计划进行的。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Oracle (ORCL) ha riportato una transazione interna su un modulo Form 4. Il 10/10/2025, un dirigente (EVP, Chief Legal Officer) ha venduto 19.758 azioni ordinarie al prezzo di $300 per azione, codificata come “S.” A seguito della vendita, l’ufficiale deteneva direttamente 18.429 azioni. Il deposito indica che la vendita è stata effettuata nell’ambito di un piano di negoziazione Rule 10b5-1 adottato il 10 luglio 2025.

Oracle (ORCL) informó una operación de insider en un Formulario 4. El 10/10/2025, un ejecutivo (EVP, Chief Legal Officer) vendió 19,758 acciones comunes a $300 por acción, codificado como “S.” Tras la venta, el ejecutivo poseía beneficiosamente 18,429 acciones, en forma directa. El registro señala que la venta se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 10 de julio de 2025.

Oracle (ORCL)은 Form 4에 내부자 거래를 보고했습니다. 2025년 10월 10일, 한 임원(EVP, 법무 최고책임자)이 일반주식 19,758주를 주당 $300에 매도했으며, 거래 유형은 “S.”로 표기됩니다. 매도 후 임원은 직접적으로 18,429주를 보유하고 있었습니다. 제출 문서는 매도가 2025년 7월 10일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 기록합니다.

Oracle (ORCL) a rapporté une transaction d’initié sur un formulaire Form 4. Le 10/10/2025, un dirigeant (EVP, Directeur juridique) a vendu 19 758 actions ordinaires à $300 par action, codé « S ». Suite à la vente, l’officier était bénéficiairement propriétaire de 18 429 actions, détenues directement. Le dossier précise que la vente a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 10 juillet 2025.

Oracle (ORCL) meldete eine Insider-Transaktion auf Formular 4. Am 10.10.2025 verkaufte ein Beauftragter (EVP, Chief Legal Officer) 19.758 Stammaktien zu $300 pro Aktie, codiert „S“. Nach dem Verkauf hielt der Beauftragte direkt 18.429 Aktien im Eigentum. Die Einreichung vermerkt, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelplans adoptiert am 10. Juli 2025 stattfand.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Levey Stuart

(Last) (First) (Middle)
C/O DELPHI ASSET MGMT CORPORATION
200 S. VIRGINIA ST., SUITE 625

(Street)
RENO NV 89501

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 S(1) 19,758 D $300 18,429 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Sale of shares pursuant to Rule 10b5-1 Plan adopted on July 10, 2025.
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Stuart Levey (POA filed 11/08/22) 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ORCL disclose?

An officer sold 19,758 ORCL shares on 10/10/2025 at $300 per share under transaction code S.

Who is the reporting person in the ORCL Form 4?

An officer (EVP, Chief Legal Officer) is the reporting person, with direct ownership.

How many Oracle shares does the insider hold after the sale?

The officer beneficially owned 18,429 shares following the reported transaction.

Was the Oracle insider sale under a trading plan?

Yes. It was executed under a Rule 10b5-1 Plan adopted on July 10, 2025.

What was the sale price reported for the ORCL shares?

The sale price reported was $300 per share.

What is the ownership form reported for the remaining shares?

The filing indicates Direct (D) ownership for the remaining shares.
Oracle Corp

NYSE:ORCL

ORCL Rankings

ORCL Latest News

ORCL Latest SEC Filings

ORCL Stock Data

865.56B
1.68B
41.55%
45.19%
0.76%
Software - Infrastructure
Services-prepackaged Software
Link
United States
AUSTIN